The development of personalised treatments that target rare paediatric cancer subtypes can be enhanced through global collaboration. But geography and rules to protect personal data in different jurisdictions can make the sharing and comparing of essential data difficult or even impossible.

The Australian BioCommons Zero Childhood Cancer Flagship project is a collaborative partnership between ZERO Childhood Cancer (https://www.zerochildhoodcancer.org.au/), D3b at Children’s Hospital of Philadelphia (https://d3b.center/), Seven Bridges (https://www.sevenbridges.com/), Australian Research Data Commons (https://ardc.edu.au/) and the Australian BioCommons (https://www.biocommons.org.au/) to unite and harmonise the analysis of paediatric cancer data sets from Australia (ZERO) and the US (Kids First Data Resource https://kidsfirstdrc.org/) using the cloud-based Cavatica analysis platform (https://docs.cavatica.org/). The project allows ZERO and Kids First workflows and analysis tools to be used interchangeably and seamlessly across both datasets, effectively aggregating the separate datasets into a single virtual pan-continental dataset.

This webinar highlights the outcomes of the project and how the platform can be used to enhance human genomics studies and patient outcomes. Future plans are also discussed.

Presenters: Mark Cowley (Children's Cancer Institute), Jack DiGiovanna (Seven Bridges), Allison Heath (Children’s Hospital of Philadelphia)

This webinar was recorded on 21 January 2021

See upcoming webinars and workshops on our website:
https://www.biocommons.org.au/events